This visit was part of the 4 st Steering Committee Meeting, that took place on the 11 and 12 of January, in the Hotel Vila Galé Coimbra.
Folsmart explicitly aims for a treatment improvement in RA and focuses in particular on folate-targeted nanodevices for the activation of macrophages. The main objective of FOLSMART is the translation of the laboratory-based medication into Phase I clinical trials.
Since January 1st 2016 the EU funds a research project devoted to the field of Rheumatoid Arthritis (RA) under its Horizon 2020 programme (NMP PILOTS).
For more information: http://folsmart.net
